myTcell

myTcell guides physicians in logistics and toxicity management of CARs and BiTEs

Developed by: Dr. Viktoria Blumenberg, Dr. Veit Bücklein, Prof. Dr. Marion Subklewe

Please note: this app was developed by hematologists for health care professionals only to guide pre-treatment logistics and management of CAR T cell and BiTE related toxicities based on national and international consented guidelines. It is not intended for patient-use.

Provide High-Level Patient Care During the Pre-Treatment Workflow

• Get disease and product specific guidance through the clinical workflow of cell therapy in a step by step process

• Receive recommendations for patient screening and safety assessment

• Be aware of stopping rules of several medications prior to leukapheresis and CAR T-cell transfusion

Learn How to Manage CRS, ICANS, HLH, Pancytopenia and Infections

• Gain knowledge about the incidence and clinical signs of T-cell related i. immunotoxicities

• Refer to international consented grading scales for CRS and ICANS

• Grade and manage toxicity through interactive grading tools for CRS, ICANS and HLH (e.g. ICE-Score, HScore)

• Assess and treat pancytopenia and infections including the initiation of respective antimicrobial prophylaxis

Stay up to Date on Latest Research Findings in the Field

• Browse through results of clinical trials, case reports, translational research findings and reviews to support your decision-making and to promote evidence based medicine

Connect with CAR T cell Treatment Centers

• Find the nearest treatment center and get in contact with the local CAR T-cell team to facilitate the referral of your patient

myTcell has been certified as medicinal product class I. App development has been funded through educational grants by Celgene, Gilead Sciences, Janssen and Novartis.